Article
HypoxamicroRNA-210 protects against hepatic steatosis by inhibiting CIDEC expression
2025-12-20
Abstract excerpt
<h4>Background and Aims:</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major global health burden. Although hypoxia is known to contribute to MASLD pathogenesis, the role of hypoxia signaling remains poorly defined. We investigated whether HypoxamicroRNA-210 (miR-210), a key hypoxia-inducible microRNA, regulates hepatic lipid metabolism and MASLD development. <h4>Methods:</h4> Serum...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54cb63b6-d00d-58f7-8d2d-50a4d98ab90b
- DOI
- 10.64898/2025.12.19.695309
